![Individual Patient Expanded Access: Developing Principles For A Structural And Regulatory Framework | Health Affairs Individual Patient Expanded Access: Developing Principles For A Structural And Regulatory Framework | Health Affairs](https://www.healthaffairs.org/do/10.1377/forefront.20140731.040491/full/George_Figure1-1642702428308.jpg)
Individual Patient Expanded Access: Developing Principles For A Structural And Regulatory Framework | Health Affairs
![Expanded Access vs. Right to Try: What Patients Need to Know » Triage Cancer | Finances-Work-Insurance Expanded Access vs. Right to Try: What Patients Need to Know » Triage Cancer | Finances-Work-Insurance](https://triagecancer.org/wp-content/uploads/2020/07/Tableedit.png)
Expanded Access vs. Right to Try: What Patients Need to Know » Triage Cancer | Finances-Work-Insurance
![Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO](https://www.gao.gov/assets/extracts/b1ea33f945c9bdf9de3fd32fc2df69d8/rId13_image4.png)
Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO
![Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644620305092-gr1.jpg)
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect
![U.S. FDA on Twitter: "Have you heard of “Expanded Access?” It's a potential pathway for patients with immediately life-threatening conditions to gain access to an investigational medial product. Here's how the process U.S. FDA on Twitter: "Have you heard of “Expanded Access?” It's a potential pathway for patients with immediately life-threatening conditions to gain access to an investigational medial product. Here's how the process](https://pbs.twimg.com/media/D76tdsTW4AACocc.jpg)